Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00366522 | Study Evaluating LXR-623 in Healthy Subjects | PHASE1 | COMPLETED | - | — | — | Aug 1, 2006 | Sep 1, 2006 | Aug 7, 2009 | 1 | United States |
| NCT00385489 | Study Evaluating LXR-623 in Healthy Japanese Adults | PHASE1 | COMPLETED | - | — | — | Aug 1, 2006 | Sep 1, 2006 | Aug 7, 2009 | 1 | Japan |
| Name | Type | Description |
|---|---|---|
| LXR-623 | DRUG | - |
Inclusion: * Healthy, men or women, aged 19-50 years Exlcusion: * Use of any investigational or prescription drug within 30 days before study start * Any clinically imprtant medical disease or abnormal laboratory test results